Abstract
Radiotherapy plays a critical role in the nodal management of patients with head and neck cancer. The indications, dose fractionation schedules, and results of postoperative radiation therapy (PORT) and elective nodal management (ENI) in various head and neck cancers are reviewed and summarized with common themes identified.
Keywords: Elective irradiation, head and neck cancer, lymph nodes, postoperative irradiation, skin cancer.
Current Cancer Therapy Reviews
Title:Review of Postoperative and Elective Nodal Irradiation in Head and Neck Cancer
Volume: 10 Issue: 4
Author(s): Daniel M. Trifiletti, Austin Sim, David D. Wilson and Paul W. Read
Affiliation:
Keywords: Elective irradiation, head and neck cancer, lymph nodes, postoperative irradiation, skin cancer.
Abstract: Radiotherapy plays a critical role in the nodal management of patients with head and neck cancer. The indications, dose fractionation schedules, and results of postoperative radiation therapy (PORT) and elective nodal management (ENI) in various head and neck cancers are reviewed and summarized with common themes identified.
Export Options
About this article
Cite this article as:
Trifiletti M. Daniel, Sim Austin, Wilson D. David and Read W. Paul, Review of Postoperative and Elective Nodal Irradiation in Head and Neck Cancer, Current Cancer Therapy Reviews 2014; 10 (4) . https://dx.doi.org/10.2174/157339471004150407125249
DOI https://dx.doi.org/10.2174/157339471004150407125249 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Highlights in Peptide Nanoparticle Carriers Intended to Oral Diseases
Current Topics in Medicinal Chemistry Training Children to Reduce Motion and Increase Success of MRI Scanning
Current Medical Imaging Targeted Therapies in Head and Neck Cancer: Past, Present and Future
Reviews on Recent Clinical Trials Viral Vectors for Gene-Directed Enzyme Prodrug Therapy
Current Gene Therapy Irradiation Toxicity and Inflammatory Bowel Diseases (IBD): Review
Reviews on Recent Clinical Trials Treatment of Chronic Hypercalcemia
Medicinal Chemistry MicroRNA in the Pathogenesis and Prognosis of Esophageal Cancer
Current Pharmaceutical Design Advances in Hydrogels Applied to Degenerative Diseases
Current Pharmaceutical Design Antineoplastic Activities, Apoptotic Mechanism of Action and Structural Properties of a Novel Silver(I) Chelate
Current Medicinal Chemistry Anti-Tumor Vaccines in Head and Neck Cancer: Targeting Immune Responses to the Tumor
Current Cancer Drug Targets Cancer Proteomics: New Horizons and Insights into Therapeutic Applications
Current Proteomics Cellular Delivery In Vivo of siRNA-Based Therapeutics
Current Pharmaceutical Design Expression and Function of the Transient Receptor Potential Ion Channel Family in the Hematologic Malignancies
Current Molecular Pharmacology Meet Our Editorial Board Member
Reviews on Recent Clinical Trials Potential Association Between TLR4 and Chitinase 3-Like 1 (CHI3L1/YKL-40) Signaling on Colonic Epithelial Cells in Inflammatory Bowel Disease and Colitis-Associated Cancer
Current Molecular Medicine Oral HPV Infection: Current Strategies for Prevention and Therapy
Current Pharmaceutical Design Phenylbutyric Acid: Simple Structure - Multiple Effects
Current Pharmaceutical Design TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges
Reviews on Recent Clinical Trials Epigenetic Reprogramming and Landscape of Transcriptomic Interactions: Impending Therapeutic Interference of Triple-Negative Breast Cancer in Molecular Medicine
Current Molecular Medicine Enkephalin-Fentanyl Multifunctional Opioids as Potential Neuroprotectants for Ischemic Stroke Treatment
Current Pharmaceutical Design